<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Aspirantskiy Vestnik Povolzhiya</journal-id><journal-title-group><journal-title xml:lang="en">Aspirantskiy Vestnik Povolzhiya</journal-title><trans-title-group xml:lang="ru"><trans-title>Аспирантский вестник Поволжья</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-2354</issn><issn publication-format="electronic">2410-3764</issn><publisher><publisher-name xml:lang="en">Samara State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">24988</article-id><article-id pub-id-type="doi">10.17816/2072-2354.2011.0.5-6.199-206</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The system approach to the introduction of new medical technologies in hematology</article-title><trans-title-group xml:lang="ru"><trans-title>Системный подход внедрения новых медицинских технологий в гематологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tyumina</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Тюмина</surname><given-names>О В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГБУЗСО «Клинический центр клеточных технологий»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2011</year></pub-date><volume>11</volume><issue>5-6</issue><issue-title xml:lang="en">NO5-6 (2011)</issue-title><issue-title xml:lang="ru">№5-6 (2011)</issue-title><fpage>199</fpage><lpage>206</lpage><history><date date-type="received" iso-8601-date="2020-03-11"><day>11</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Tyumina O.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Тюмина О.В.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Tyumina O.V.</copyright-holder><copyright-holder xml:lang="ru">Тюмина О.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://aspvestnik.ru/2410-3764/article/view/24988">https://aspvestnik.ru/2410-3764/article/view/24988</self-uri><abstract xml:lang="en"><p>The system analysis of the stages of the introduction of new medical technologies into practical public health based on the example of the introduction of the technology of the cord blood bank in the Samara region is carried out. The determination of the economic benefit of this technology is carried out. The necessary stages for the successful introduction of any new medical technology are proposed.</p></abstract><trans-abstract xml:lang="ru"><p>В исследовании проведён системный анализ этапов внедрения новых медицинских технологий в практическое здравоохранение на примере внедрения технологии заготовки, обработки и криохранения пуповинной крови в Самарской области, проведён фармакоэкономический анализ данной технологии. Предложены необходимые этапы для успешного внедрения любой новой медицинской технологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>medical technologies pharmacoeconomics</kwd><kwd>cord blood</kwd><kwd>analysis «costeffectiveness»</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>медицинская технология</kwd><kwd>фармакоэкономика</kwd><kwd>пуповинная кровь</kwd><kwd>анализ «затратыэффективность»</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Владимирская Е.Б. Дифференцированные потенции стволовых гемопоэтических клеток / Е.Б. Владимирская, А.Г. Румянцев// Вопросы гематологии/онкологии и иммунопатологии в педиатрии.- 2002.- № 1.- С. 7-11.; Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gluckman E., Broxmeyer H.E., Auerbach A.D. et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord from an HLA - identical sibling // N. Engl. J. Med.- 1989.- Vol.321.- P.1184-1178.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ashfaq K, Yahaya I, Hyde C, Andronis L,et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.//Health Technol Assess.- 2010.- 14(54).- P.11-30.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.// JAMA.- 2009.- Vol.301(22).-P.2349-2361.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Atsuta Y, Suzuki R, Nagamura-Inoue T et al. Disease-specific analyses of unrelated cord blood transplantation with acute leukemia compared with unrelated bone marrow transplantation in adult patients. //Blood.- 2009.- Vol.113.- P.1631-1638.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ashfaq K, Yahaya I, Hyde C, Andronis L,et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.//Health Technol Assess.- 2010.- 14(54).- P.11-30.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Atsuta Y, Suzuki R, Nagamura-Inoue T et al. Disease-specific analyses of unrelated cord blood transplantation with acute leukemia compared with unrelated bone marrow transplantation in adult patients. //Blood.- 2009.- Vol.113.- P.1631-1638.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.// Lancet. -2010.- Vol.11(7).- P.653-660.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.// JAMA.- 2009.- Vol.301(22).-P.2349-2361.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Howard D, Maiers M, Kollman C, et al. A cost-benefit analysis of increasing cord blood inventory levels / Cord blood. // Washington DC.- 2005. –P.221-241.; Kollman C, Esteban A, Baitty T, et al. Assessment of optimal size and composition of the U.S. national registry of hematopoietic stem cell donors.// Transplantation. – 2004.-Vol.78(1) – P. 89-95.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kollman C, Esteban A, Baitty T, et al. Assessment of optimal size and composition of the U.S. national registry of hematopoietic stem cell donors.// Transplantation. – 2004.-Vol.78(1) – P. 89-95.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Чисов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2009 году.// М.: АН ТИФ, 2010. 186 с.; По данным www.//gks.ru</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Howard D, Maiers M, Kollman C, et al. A cost-benefit analysis of increasing cord blood inventory levels / Cord blood. // Washington DC.- 2005. –P.221-241.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.// Blood.- 2001.- Vol.97.- P.2962–2971.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>http://www.minzdravsoc.ru</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>http://minzdravsoc.samregion.ru</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>www.//gks.ru</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Ягудина Р.И., Куликов А.Ю., Нгуен Т.Определение «порога готовности платить» в России, в Европейских странах и в странах СНГ. // Фармакоэкономика. – 2011. - №1.- с.7-11.</mixed-citation></ref></ref-list></back></article>
